![TESAMORELIN + IPAMORELIN [5mg/5mg]](/media/2026/09/Group-34.webp?dpl=dpl_2VbZc7rA9XzjC5BxFemazEnTP5CL)
Earn up to 140 points.
Stock up. Stable for 24 months lyophilized at −20°C.
1 bottle · TESAMORELIN + IPAMORELIN [5mg/5mg]
Research use only · Not for human or veterinary use
Compound Profile
The linked COA from Optiq Health Labs identifies Tesamorelin + Ipamorelin for lot TI10-0909-ZE. Reported purity: 99.6% (overall blend result). Measured net content: 5.11/5.43 mg/vial. Endotoxin result: PASS. Report date: September 15, 2026. Nominal label strength and measured net content are distinct. Separate per-component purity percentages are not reported.
View Signed COA
Tesamorelin is a synthetic 44-amino-acid analog of growth hormone-releasing hormone (GHRH) with a stabilizing N-terminal hexenoyl modification that resists enzymatic degradation. It is the only GHRH-analog peptide approved by the FDA for any indication, originally for HIV-associated lipodystrophy under the brand name Egrifta. Documented research spans GH/IGF-1 axis stimulation, visceral adipose tissue biology, hepatic fat metabolism, and lipid profile modulation.
Selected Studies · Peer-Reviewed Literature
A curated list of published peer-reviewed papers indexed in PubMed where TESAMORELIN + IPAMORELIN [5mg/5mg] has been studied. Provided for research-context only. Linking to the literature does not constitute endorsement of any therapeutic application.
At Elixser Peptides, quality comes first. Our peptides are produced using advanced manufacturing processes and verified through comprehensive testing protocols to deliver dependable results for research applications.
Transparency
Each batch ships with a third-party Certificate of Analysis from BioRegen Analytical. HPLC purity, mass-spectrometry identity, net content, and LAL endotoxin screening. Every test, every lot.
Your lot number ships on the label and on the COA. Enter it in the verifier any time to retrieve the original lab report.
Common Reviews
Customer Reviews
Common Questions

Featured Collection – Premium purity compounds crafted with consistency, precision, and quality in mind.
Shop CatalogThe combination is a classical research-stack pairing: a GHRH analog (Tesamorelin) plus a GHRP-family secretagogue (Ipamorelin), each acting on a different point of the somatotrophic axis. Neither compound has been approved by the FDA for human use outside the original GHRH-research and HIV-associated lipodystrophy context. Both remain classified as research compounds outside that approved indication.
50mg / 10mg / 10mg per vial
10mg / 5mg per vial
500mcg SLU-PP-332 / capsule · 100 capsules
Jon Bell
Still waiting g for it to arrive
William Burke
Good so far
JARRETT CARR
Works well. I see immediate results!